Adjuvant effects of chemotherapeutics and Metformin on MFE-319 endometrial carcinoma cell line
Authors:
Open Access
- 1 April 2021
- journal article
- research article
- Published by Societatea Romana de Morfologie in Romanian Journal of Morphology and Embryology
- Vol. 61 (3) , 707-714
Abstract
We aimed to investigate the cytotoxicity of Metformin, Cisplatin, and Paclitaxel on MFE-319 endometrial carcinoma cell line using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and immunocytochemistry assays. Half maximal inhibitory concentration (IC50) doses of three drugs alone and in the dual combinations were applied to the cells. Immunocytochemical method was performed for the cell survival and for phosphatidylinositol 3-kinase (PI3K), phosphorylated extracellular regulated kinases (pErk)-1/2, Akt-1, phosphorylated Akt (pAkt)-1/2/3 cell growth markers and angiogenic vascular endothelial growth factor (VEGF). Immunoreactivities were evaluated using H-score and analyzed using the one-way analysis of variance (ANOVA) test for statistics. It was found that these drugs caused a decrease in the immunoreactivities of these markers. Particularly, dual combination of Paclitaxel and Cisplatin decreased the immunoreactivities of PI3K, pErk-1/2, Akt-1, and pAkt-1/2/3. Cisplatin and Paclitaxel were more effective than Metformin; on the other hand, Metformin has been shown to enhance the efficacy of these two drugs. In vitro or in vivo further studies are needed to investigate the efficacy of these three drugs via PI3K/Akt signal pathway.Keywords
This publication has 42 references indexed in Scilit:
- A Chinese herbal formula, Yi-Qi-Fu-Sheng, inhibits migration/invasion of colorectal cancer by down-regulating MMP-2/9 via inhibiting the activation of ERK/MAPK signaling pathwaysBMC Complementary and Alternative Medicine, 2013
- Metformin-mediated downregulation of p38 mitogen-activated protein kinase-dependent excision repair cross-complementing 1 decreases DNA repair capacity and sensitizes human lung cancer cells to paclitaxelBiochemical Pharmacology, 2013
- Targeting metabolism for cancer treatment and prevention: metformin, an old drug with multi-faceted effectsOncogene, 2012
- Cellular and molecular mechanisms of metformin: an overviewClinical Science, 2011
- Diabetes and CancerDiabetes Care, 2010
- Metformin is a potent inhibitor of endometrial cancer cell proliferation—implications for a novel treatment strategyGynecologic Oncology, 2010
- Pharmacotherapy of endometrial cancerExpert Opinion on Pharmacotherapy, 2009
- Management of Advanced-Stage and Recurrent Endometrial CancerSeminars in Oncology, 2009
- Clinical and Biological Significance of Vascular Endothelial Growth Factor in Endometrial CancerClinical Cancer Research, 2007
- Tumor angiogenesis and accessibility: Role of vascular endothelial growth factorSeminars in Oncology, 2002